Effects of antiviral agents and HBV genotypes on intrahepatic covalently closed circular DNA in HBeAg-positive chronic hepatitis B patients

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 8

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

204

HTML

1645

Figures (1-2)

177

Tables (1-3)

156

Sum=2182

Feb 28, 2008 (publication date) through Apr 25, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Feb 28, 2008; 14(8): 1268-1273
Published online Feb 28, 2008. doi: 10.3748/wjg.14.1268

Figure 1 Correlation between the reduction in intrahepatic ccc DNA and a similar reduction in intrahepatic HBV DNA.

Figure 2 Relationship between intrahepatic ccc DNA level and HBeAg titer at the end of treatment.

Citation: Lu HY, Zhuang LW, Yu YY, Si CW, Li J, Zhang JJ, Zeng Z, Chen XY, Han ZH, Chen Y. Effects of antiviral agents and HBV genotypes on intrahepatic covalently closed circular DNA in HBeAg-positive chronic hepatitis B patients. World J Gastroenterol 2008; 14(8): 1268-1273
URL: https://www.wjgnet.com/1007-9327/full/v14/i8/1268.htm
DOI: https://dx.doi.org/10.3748/wjg.14.1268